DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Pazufloxacin
Pazufloxacin
Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Cr
The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity
Effects of Repeated Oral Administration of Pazufloxacin Mesylate and Meloxicam on the Antioxidant Status in Rabbits
EMA/CVMP/158366/2019 Committee for Medicinal Products for Veterinary Use
WHO Report on Surveillance of Antibiotic Consumption: 2016-2018 Early Implementation ISBN 978-92-4-151488-0 © World Health Organization 2018 Some Rights Reserved
Pazufloxacin Mesylate | Medchemexpress
Surveillance of Antimicrobial Consumption in Europe 2013-2014 SURVEILLANCE REPORT
Antibiotic Prescribing Among Patients with Severe Infectious Diseases in Two Private Sector Hospitals in Central India – a Time Series Analysis Over 10 Years
Akhtar Saeed Medical and Dental College, Lhr
Summary Report on Antimicrobials Dispensed in Public Hospitals
Advances in Antimicrobial Resistance Monitoring Using Sensors and Biosensors: a Review
Antibiotic Classes
Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
Wo 2007/095187 A2
Enhancement of Rnai by a Small Molecule Antibiotic Enoxacin
Statistical Analysis Plan / Data Specifications the Risk of Acute Liver Injury Associated with the Use of Antibiotics. a Replica
Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
Introduction and Geographic Availability of New Antibiotics Approved Between 1999 and 2014
Top View
WO 2010/083148 Al
Quantitative Structure-Activity Relationship Model for Prediction Of
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
New Perspectives on Antibacterial Drug Research
Customs Tariff - Schedule
Review of Properties and Analytical Methods for the Determination of Norfloxacin
NICE Guideline. Urinary Tract Infection (Lower): Antimicrobial Prescribing
Clinical Study of the Efficacy of the Ophthalmic Solution of Pazufloxacin
(12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
Pazufloxacin Mesilate (Rinnm) Equivalent to About 400 Mg of Pefloxacin
(12) Patent Application Publication (10) Pub. No.: US 2015/0335704 A1 KAROLCHYK (43) Pub
PDF Download
Quantitative Structure–Activity Analysis of Cross-Reactivities
Customs Tariff - Schedule Xxi - 1
AMR: Antimicrobial Resistance Data Analysis
INHIBITION of PROTEIN-PROTEIN INTERACTIONS in MYCOBACTERIUM TUBERCULOSIS Paige Chan, Grace Chun
Wo 2007/044693 A2
A Novel Predictive Model for the Anti-Bacterial, Anti-Malarial and Herg Cardiac QT Prolongation Properties of Fluoroquinolones Clifford Fong
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Quantitative Comparison of the Convulsive Activity of Combinations of Twelve Fluoroquinolones with Five Nonsteroidal Antiinflammatory Agents
From Chloroquine to Antineoplastic Drugs? the Story of Antibacterial Quinolones
Critically Important Antimicrobials for Human Medicine, 6Th Revision
University of Oklahoma
Effects of Repeated Oral Administration of Pazufloxacin Mesylate and Meloxicam on the Antioxidant Status in Rabbits
WHO List of Critically Important Anti-‐Microbials, 2011 Rev 3
Rutinemessig Publisering Av Forbruksdata for Antibakterielle Midler Rapportert Til Vetreg VETERINÆRINSTITUTTET
Harmonized Tariff Schedule of the United States (2006) (Rev
Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
(12) Patent Application Publication (10) Pub. No.: US 2010/0087409 A1 Freehauf Et Al
Critically Important Antimicrobials for Human Medicine
Summary of Investigation Results Fluoroquinolones and Quinolones (Oral and Injectable Dosage Forms)
ARPEC Protocol for Drug Utilization Study
Antibiotic Use and Resistance in Food Animals Current Policy and Recommendations © Center for Disease Dynamics, Economics & Policy, 2016
Surveillance of Antimicrobial Consumption in Europe 2012 Surveillance of Antimicrobial Consumption in Europe 2012
Revision of Precautions Ofloxacin (Oral Dosage Form)
Quinolone Synthesis
Inductive QSAR Descriptors. Distinguishing Compounds with Antibacterial Activity by Artificial Neural Networks